These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9891555)

  • 41. [Prognosis and prognostic factors in oncology and oncologic surgery ].
    Gorbunov EA; Wechsler J
    Vnitr Lek; 2004 Jan; 50(1):61-5. PubMed ID: 15015231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.
    Geisler SA; Olshan AF; Weissler MC; Cai J; Funkhouser WK; Smith J; Vick K
    Clin Cancer Res; 2002 Nov; 8(11):3445-53. PubMed ID: 12429633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 44. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
    Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
    Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in head and neck adenoid cystic carcinoma.
    da Cruz Perez DE; de Abreu Alves F; Nobuko Nishimoto I; de Almeida OP; Kowalski LP
    Oral Oncol; 2006 Feb; 42(2):139-46. PubMed ID: 16249115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors in squamous cell carcinomas of the head and neck.
    Liu M; Weynand B; Delos M; Marbaix E
    Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
    Sackett MK; Bairati I; Meyer F; Jobin E; Lussier S; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B
    Clin Cancer Res; 2008 Jan; 14(1):67-73. PubMed ID: 18172254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
    Kopczyński P; Flieger R
    Pol Merkur Lekarski; 2013 Jul; 35(205):37-8. PubMed ID: 23984603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surfing prognostic factors in head and neck cancer at the millennium.
    Chiesa F; Mauri S; Tradati N; Calabrese L; Giugliano G; Ansarin M; Andrle J; Zurrida S; Orecchia R; Scully C
    Oral Oncol; 1999 Nov; 35(6):590-6. PubMed ID: 10705095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of the anatomopathologic variables in head and neck cancer.
    Saba LM
    Rev Paul Med; 1993; 111(4):8-10. PubMed ID: 8108653
    [No Abstract]   [Full Text] [Related]  

  • 52. Head and neck cancer. Head and Neck Oncology Workgroup, Legislative Task Force on Cancer in Texas.
    Goepfert H; Barker JL; Close LG; el-Domeiri AH; Epley DE; Helfrick JF; Hong WK; Lehane DE; Neal GD; O'Brien JC
    Tex Med; 1987 Sep; 83(9 Pt 2):4-16. PubMed ID: 3672404
    [No Abstract]   [Full Text] [Related]  

  • 53. Outcomes toolbox for head and neck cancer research.
    Ringash J; Bernstein LJ; Cella D; Logemann J; Movsas B; Murphy B; Trotti A; Wells N; Yueh B; Ridge J
    Head Neck; 2015 Mar; 37(3):425-39. PubMed ID: 24318166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of magnetic resonance spectroscopy for diagnosis of head tumors].
    Reiman V; Holtmann S; Hamburger C; Hochstrasser K; Kastenbauer E
    Biomed Tech (Berl); 1990; 35 Suppl 3():254-5. PubMed ID: 2078721
    [No Abstract]   [Full Text] [Related]  

  • 55. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology.
    Ogden GR
    J Pathol; 1997 Mar; 181(3):347-8. PubMed ID: 9155723
    [No Abstract]   [Full Text] [Related]  

  • 56. Optimizing treatment in head and neck cancers -- are molecular markers the answer?
    D'cruz AK; Mulherkar R
    Indian J Med Res; 2005 Sep; 122(3):196-8. PubMed ID: 16251774
    [No Abstract]   [Full Text] [Related]  

  • 57. Updated National Comprehensive Cancer Network guidelines for treatment of head and neck cancers 2010-2017.
    Wierzbicka M; Napierała J
    Otolaryngol Pol; 2017 Dec; 71(6):1-6. PubMed ID: 29327681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Standardizing treatment: a crisis in cancer care.
    Lewis CM; Weber RS
    Otolaryngol Clin North Am; 2013 Aug; 46(4):671-9. PubMed ID: 23910477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance and prognostic impact of co-morbidity in head and neck cancer.
    Kazi R; Nutting CM; Rhys-Evans P; Harrington KJ
    J Cancer Res Ther; 2009; 5(3):145-7. PubMed ID: 19841553
    [No Abstract]   [Full Text] [Related]  

  • 60. Effective health care: management of head and neck cancers.
    Collins R; Flynn A; Melville A; Richardson R; Eastwood A
    Qual Saf Health Care; 2005 Apr; 14(2):144-8. PubMed ID: 15805462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.